No Data
No Data
Chimerix, Inc. (CMRX) Q3 2024 Earnings Call Transcript Summary
Chimerix, Inc. (CMRX) Q3 2024 Earnings Call Transcript
TD Cowen Maintains Chimerix(CMRX.US) With Buy Rating, Maintains Target Price $8
JonesTrading Maintains Chimerix(CMRX.US) With Buy Rating, Maintains Target Price $5
Chimerix's Positive Phase 3 Trial Progress and Strong Financial Position Justify 'Buy' Rating
Chimerix Reports Q3 2024 Results and Study Progress
No Data
No Data